Skip to main content
EcoSphere News
HealthDemocratic Republic of Congo

Mpox Cases Decline in DR Congo, WHO Reports Significant Progress Amid Ongoing Vigilance

Vaccination efforts lead to a reduction in new mpox infections in the Democratic Republic of Congo, yet health experts urge continued caution.

Source: bbc.co.uk1 min read
Mpox Cases Decline in DR Congo, WHO Reports Significant Progress Amid Ongoing Vigilance
Image via bbc.co.uk

In brief

Recent reports from the Democratic Republic of Congo (DRC) indicate a significant drop in mpox cases, as health officials confirm a plateau in new infections due to vaccination efforts launched last month. The World Health Organization (WHO) corroborates this trend, recognizing that although new cases are decreasing, it remains too early to determine the full impact of the vaccinations on the outbreak.

At the Lwiro clinic, situated an hour from Bukavu in eastern DRC, healthcare workers observed a shift in the patient load, with daily cases declining from over ten to just two or three. Nurse Emmanuel Fikiri reflected on the newfound calm, thanks to high community vaccine uptake after the DRC received 265,000 vaccine doses from global partners in October.First identified in humans in 1970, mpox, often called monkeypox, has proven especially deadly in DRC this year, resulting in at least 900 fatalities. As health officials gear up for critical meetings to assess the global health status of mpox, they remain cautious. Dr. Jean Kaseya from the Africa Centres for Disease Control and Prevention highlighted that nearly 30% of affected individuals are children, a demographic not yet eligible for vaccines as WHO recently approved a new vaccine intended for children. The urgent need for vaccines for this vulnerable age group is evident, particularly as they can serve as vectors for transmission.Reflecting on improved community response, nurse Jackson Murhula noted, “It started to slow down...but we can't confirm the disease is fully stabilized.” While the situation appears promising, Dr. Samuel Boland, WHO’s incident manager for mpox, warns against premature conclusions, stating that a large number of cases still linger within DRC, Uganda, and Rwanda.The WHO continues to pursue vigorous vaccination campaigns alongside heightened surveillance to combat mpox, emphasizing that many lives hang in the balance and underscoring the importance of sustained intervention efforts. As health officials assess current trends, DRC remains at the center of the global health dialogue concerning pmox, and efforts to control its spread must be intensified to avert further outbreaks.

Topics

More on this story